Koers Oragenics Inc Nyse
Aandelen
US6840232036
Biotechnologie & Medisch Onderzoek
Omzet 2022 | 0,13 0,12 | Omzet 2023 | 0,04 0,03 | Marktkapitalisatie | 14,46 mln. 13,3 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -14 mln. -12,88 mln. | Nettowinst (verlies) 2023 | -20 mln. -18,41 mln. | EV/omzet 2022 | 11.842.208 x |
Nettoliquiditeiten 2022 | 10,8 mln. 9,94 mln. | Nettoliquiditeiten 2023 | 3,16 mln. 2,91 mln. | EV/omzet 2023 | 299.979.895 x |
K/w-verhouding 2022 |
-0,89
x | K/w-verhouding 2023 |
-0,61
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 76,77% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Joseph Redmond
CEO | Chief Executive Officer | 64 | 28/12 |
Janet Huffman
DFI | Director of Finance/CFO | 52 | 07-03-23 |
Kimberly Murphy
BRD | Director/Board Member | 62 | 01-05-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Charles Pope
CHM | Chairman | 73 | 04-06-10 |
John Gandolfo
BRD | Director/Board Member | 63 | 04-10-23 |
Robert Koski
BRD | Director/Board Member | 65 | 30-06-09 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+7,52% | 113 mld. | |
+11,38% | 106 mld. | |
+1,40% | 22,27 mld. | |
-12,64% | 22,22 mld. | |
-5,20% | 19,43 mld. | |
-37,85% | 17,87 mld. | |
-8,58% | 17,24 mld. | |
+7,77% | 14,29 mld. | |
+37,41% | 12,52 mld. |